Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,025.00    0.00 (0.00%)
Bid:
6,020.00
Ask:
6,030.00
Spread: 10.00 (0.166%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Interim Management Statement

5 Feb 2019 07:00

RNS Number : 0414P
DCC PLC
05 February 2019
 

 

 

5 February 2019

 

DCC plc

 

Interim Management Statement

 

Trading in line with expectations

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement for the third quarter ended 31 December 2018.

 

Third quarter ended 31 December 2018

Group operating profit for the third quarter ended 31 December 2018 was significantly ahead of the prior year and in line with expectations, notwithstanding the milder winter weather conditions.

 

DCC LPG recorded strong operating profit growth. The business benefited from the first-time contribution from the prior year acquisitions of Retail West, TEGA and Shell Hong Kong & Macau, which continued to perform in line with expectations. Organically, the business performed well, despite the mild winter weather conditions experienced in the quarter, which impacted heating related volumes in Europe.

 

DCC Retail & Oil delivered strong organic operating profit growth, driven by good performances from the businesses in Britain and Denmark, despite the milder weather, and a robust performance in France where the business was impacted by the regular nationwide protests.

Operating profit in DCC Healthcare was well ahead of the prior year. DCC Vital generated strong organic profit growth and continued to strengthen its market position in GP supplies and medical devices in Britain. DCC Health & Beauty Solutions again delivered good organic growth in both nutrition and beauty and benefited from the first-time contribution from Elite One Source, which was acquired in the prior year.

 

DCC Technology recorded strong operating profit growth, driven by the first-time contribution from acquisitions and a good organic performance in the UK and Ireland. Jam and Stampede, DCC Technology's recent North American acquisitions, have been integrated into the Group and are performing well.

 

Year ending 31 March 2019

Notwithstanding the milder winter weather conditions, DCC expects that operating profit will be significantly ahead of the prior year and will be in line with current market consensus expectations.

 

Development activity

The Group's market leading positions, combined with the recent significant development activity and its strong and liquid balance sheet, provide DCC with the platforms, opportunities and capabilities to build the Group into a global leader in its chosen sectors.

 

Final results

DCC expects to announce its results for the year ending 31 March 2019 on 14 May 2019.

 

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

 

Telephone: +44 20 7250 1446

Email: DCC@powerscourtgroup.com

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology.

 

DCC is an ambitious and entrepreneurial business operating in 17 countries, supplying products and services used by millions of people every day. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing over 12,000 people, DCC's four divisions are:

· DCC LPG - a leading LPG sales and marketing business with operations in Europe, the USA and Asia and a developing business in the retailing of natural gas and electricity;

· DCC Retail & Oil - a leader in the sales, marketing and retailing of transport and commercial fuels, heating oils and related products and services in Europe;

· DCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners; and

· DCC Technology - a leading sales, marketing and value-added services partner for global technology brands.

 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2018, DCC generated revenue of £14.3 billion and operating profit of £383.4 million.

 

DCC has an excellent record, delivering compound annual growth of 14% in operating profit and generating an average return on capital employed of approximately 19% over 24 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVZLFBKLFLBBK
Date   Source Headline
18th Jun 202012:25 pmRNS2020 Annual Report, Notice of AGM and Proxy Form
3rd Jun 202010:10 amRNSHolding in Company TR-1
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1
13th Jun 201911:37 amRNS2019 Annual Report, Notice of AGM and Proxy Form
31st May 20199:47 amRNSTotal Voting Rights
28th May 20197:00 amRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.